ABI
MDT icon

Adamant Biomedical Investments’s Medtronic MDT Stock Holding History

Adamant Biomedical Investments’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$8.77M Sell
121,500
-28,500
-19% -$1.98M 2.1% 10
2014
Q3 		$9.29M Buy
+150,000
New +$9.54M 2.32% 11

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Adamant Biomedical Investments's MDT Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Medtronic (MDT) stake by 19% in Q4 2014, selling an estimated $1.98M and leaving 121,500 shares worth $8.77M. The position accounts for 2.1% of the portfolio, ranked #10.

Adamant Biomedical Investments first reported a position in MDT in Q3 2014 and has held it in 2 quarters since. The position peaked at $9.29M in Q3 2014. 1,154 funds tracked by Wall St. Rank hold MDT as of Q4 2014.

  • Adamant Biomedical Investments held 121,500 shares of Medtronic worth $8.77M as of Q4 2014.
  • Adamant Biomedical Investments sold 28,500 Medtronic shares in Q4 2014, an estimated $1.98M.
  • Medtronic made up 2.1% of Adamant Biomedical Investments's portfolio in Q4 2014, its #10 holding.
  • Adamant Biomedical Investments first reported a position in Medtronic in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Medtronic position peaked at $9.29M in Q3 2014.
  • 1,154 funds tracked by Wall St. Rank held Medtronic as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.